TCL Archive ODAC Says Clear Clinical Benefit Required When Sponsors Claim Progression Delay July 17, 2009
TCL Archive ODAC’s Dilemma: Proposed Indication Created By Reliance On PSA Screening and Hormonal Treatment September 23, 2011
TCL Archive FDA Clears Avastin-Interferon Combination In Renal Cancer; Interferon Role Undefined. August 7, 2009
TCL Archive Joseph Jacobs, New Head Of alternative Medicine Office, Vows To ‘Talk Bluntly’ December 11, 1992